Literature DB >> 7057062

Lead, hypertension, and the renin-angiotensin system in rats.

W Victery, A J Vander, J M Shulak, P Schoeps, S Julius.   

Abstract

Rats were exposed continuously to Pb in utero and after birth by giving their mothers, during pregnancy and lactation, drinking water containing 0, 100, or 500 ppm Pb (as Pb acetate) and then continuing this regimen after weaning. Male rats received 100 ppm developed a significant elevation of systolic blood pressure (152 +/- 3.7 mm Hg vs. 135 +/- 5.6 for controls) at 3 1/2 months and remained hypertensive until sacrifice at 6 months; 500 ppm rats remained normotensive. Both 100 ppm and 500 ppm females remained normotensive. At 6 months, PRA was significantly reduced in the 100 ppm male group but was normal in the 500 ppm group. There were dose-dependent decreases in the AII/PRA ration and in renal renin. Pulmonary converting enzyme activity was not changed by Pb exposure. Blood [Pb] was 40 and 71 mug/dl, respectively, and kidney [Pb] was 4.8 and 22.9 mug/gm. Renal histology was normal in the 100 ppm group. We conclude that doses of Pb which produce blood [Pb] seen in many people are capable of inducing modest hypertension in male rats; higher doses fail to do so. The hypertension is associated with a reduction in PRA and All and therefore is unlikely to be due to hyperactivity of the RAS. (J Lab Clin Med 99:354, 1982.)

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7057062

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  24 in total

Review 1.  Lead intoxication--new insights into an old problem.

Authors:  R Nowack; E Ritz
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

Review 2.  Toxicity of lead at low dose.

Authors:  P J Landrigan
Journal:  Br J Ind Med       Date:  1989-09

3.  Lead, ferritin, zinc, and hypertension.

Authors:  C J Lockett; D Arbuckle
Journal:  Bull Environ Contam Toxicol       Date:  1987-06       Impact factor: 2.151

4.  Blood lead concentrate and blood pressure after CCl4 treatment.

Authors:  H F Loyke
Journal:  Bull Environ Contam Toxicol       Date:  1985-05       Impact factor: 2.151

5.  Kidney effects in long term exposed lead smelter workers.

Authors:  L Gerhardsson; D R Chettle; V Englyst; G F Nordberg; H Nyhlin; M C Scott; A C Todd; O Vesterberg
Journal:  Br J Ind Med       Date:  1992-03

6.  Lead and hypertension in a sample of middle-aged women.

Authors:  S A Korrick; D J Hunter; A Rotnitzky; H Hu; F E Speizer
Journal:  Am J Public Health       Date:  1999-03       Impact factor: 9.308

Review 7.  Lead poisoning.

Authors:  P J Landrigan; A C Todd
Journal:  West J Med       Date:  1994-08

Review 8.  Chronic low-level lead exposure. Its role in the pathogenesis of hypertension.

Authors:  D S Sharp; C E Becker; A H Smith
Journal:  Med Toxicol       Date:  1987 May-Jun

9.  The effects of chronic lead treatment and hypertension on the severity of cardiac arrhythmias induced by coronary artery occlusion or by noradrenaline in anaesthetised rats.

Authors:  M J Evis; K Dhaliwal; K A Kane; M R Moore; J R Parratt
Journal:  Arch Toxicol       Date:  1987-02       Impact factor: 5.153

10.  The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men.

Authors:  S J Pocock; A G Shaper; D Ashby; H T Delves; B E Clayton
Journal:  Environ Health Perspect       Date:  1988-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.